Comorbidity among patients with community-acquired pneumonia combined with coronavirus disease
DOI:
https://doi.org/10.14739/2409-2932.2025.3.338591Keywords:
community-acquired pneumonia, inflammatory markers, comorbidity, thrombosis, coronavirus disease, SARS-CoV-2, COVID-19Abstract
The aim of the work is to analyze and evaluate data from professional literature sources regarding comorbid conditions among patients with community-acquired pneumonia combined with coronavirus disease.
Materials and methods. Using primary sources from the scientometric databases Scopus, Web of Science, PubMed, a retrospective analysis of literature data on the issue of comorbidity in patients with community-acquired pneumonia combined with coronavirus disease for 2020–2025 was conducted.
Results. This article examines the impact of comorbid cardiovascular diseases during COVID-19 and the mortality rate. Literature analysis shows that the presence of cardiovascular diseases increases the chances of developing a severe course of COVID-19 by three times. Elderly people and patients with hypertension and diabetes have the worst prognosis for COVID-19. Studies indicate increased morbidity and mortality among patients with diabetes, as well as the relationship between glucose levels and disease severity. The works of various authors emphasize the importance of early diagnosis and hospitalization, as well as the need for an integrated approach to treatment, including the cooperation of cardiologists and pulmonologists. It is also noted that patients with chronic diseases, such as bronchial asthma and chronic obstructive pulmonary disease, are at higher risk of severe COVID-19. The article also discusses the mechanisms of inflammatory damage to the heart that are detected during the disease and their relationship with prognosis.
Conclusions. Timely diagnosis and treatment of comorbid conditions are need to reduce the risk of complications in patients with COVID-19. The article emphasizes the important role of family doctors in monitoring and managing chronic diseases, which can significantly alleviate the course of COVID-19. The prospects for further research are to identify markers of the immunoinflammatory response to predict the course in patients with community-acquired pneumonia associated with coronavirus infection with comorbid pathology.
References
Dziublyk YO. [Community-acquired pneumonia and COVID-19: discussion issues]. Ukrainian Pulmonology Journal. 2020;(4):12-4. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2020-110-4-12-14
Pertseva ТО, Gashynova KY, Rudakova VV, Rodionova VV, Dmytrychenko VV, Kovalenko OY, et al. [Clinical and laboratory features of coronavirus disease and risk factors of lethal outcome in patients who required hospitalization during the third wave of COVID-19 in Ukraine: a single-center retrospective study]. Ukrainian Pulmonology Journal. 2022;30(4):6-18. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2022-30-4-6-18
Çalıca Utku A, Budak G, Karabay O, Güçlü E, Okan HD, Vatan A. Main symptoms in patients presenting in the COVID-19 period. Scott Med J. 2020;65(4):127-32. doi: https://doi.org/10.1177/0036933020949253
Yakovenko OK, Dziublyk YA, Lynnyk МІ. [Determination of dynamics and stage of development of COVID-19 pneumonia based on digital software processing of images of computed tomography of the chest]. Infusion & chemotherapy. 2022;5(1):16-22. Ukrainian. doi: https://doi.org/10.32902/2663-0338-2022-1-16-22
Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. doi: https://doi.org/10.1371/journal.pone.0238215
Skorokhodova NO, Fushtei IM. [The problem of managing patients with community-acquired pneumonia combined with COVID-19 in comorbid conditions (literature review)]. 2024;11(4): doi: https://doi.org/10.35339/ic.11.4.skf
Avgaitis SS, Sid EV. [The role of coronavirus infection in lung injury, which contributes to the occurrence of complicated course of community-acquired pneumonia]. Reports of Vinnytsia National Medical University. 2024;28(3):545-9. Ukrainian. doi: https://doi.org/10.31393/reports-vnmedical-2024-28(3)-28
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: https://doi.org/10.1016/S0140-6736(20)30566-3
Figliozzi S, Masci PG, Ahmadi N, Tondi L, Koutli E, Aimo A, et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13362. doi: https://doi.org/10.1111/eci.13362
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-10. doi: https://doi.org/10.1016/j.dsx.2020.04.004
Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813-22. doi: https://doi.org/10.1016/S2213-8587(20)30272-2
Melnyk VP, Panasiuk ОV, Sadomova-Andrianova ОV, Antoniuk IV, Sliusarchuk IO, et al. [Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings]. Zaporozhye medical journal. 2021;23(3):395-401. Ukrainian doi: https://doi.org/10.14739/2310-1210.2021.3.224926
Yakovenko OK, Khanin OG, Lotysh VV, Gryf SL. [Clinical features of severe COVID-19 with lethal outcome in Volyn region residents]. Ukrainian pulmonology journal. 2021;(2):16-24. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2021-29-2-16-24
Konopkina LI, Shchudro OO. [Сardiovascular system status in patients with dyspnea after COVID-19-associated pneumonia]. Ukrainian pulmonology journal. 2022;31(4):14-21. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2023-31-4-14-21
DuBuske L, Todoriko L, Koval H, Yuriev S, Semianiv І, Pashkovska N, et al. Asthma and allergy practice and COVID-19: a review. Part I. Tuberculosis, Lung Diseases, HIV Infection. 2021;(2):44-51. doi: http://doi.org/10.30978/TB2021-2-44
Lynnyk МІ, Iashyna МІ, Іgnatieva МІ, Gumeniuk GL, Opimakh SG, Polianska MA, et al. [Peculiarities of viral etiology COVID-19 community aquired pneumonia in patients with bronchial asthma]. Asthma and allergy. 2022;(1-2):15-26. Ukrainian. doi: https://doi.org/10.31655/2307-3373-2022-1-2-15-26
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis. J Med Virol. 2020;92(10):1915-21. doi: https://doi.org/10.1002/jmv.25889
Dovgan AO, Konstantinovych TV. [Peculiarities of diagnosis and treatment of patients with post-COVID-19 interstitial lung anomaly on an example of clinical cases]. Ukrainian pulmonology journal. 2024;32(3):35-9. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2024-32-3-35-39
Fushtei IM, Mochonyi VO, Soloviov OV. [The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection]. Zaporozhye medical journal. 2025;27(1):95-100. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2025.1.316504
Pertseva TO, Gabshidze NO. [The risk factors for thrombosis in patients recovered after community acquired pneumonia associated with COVID-19]. Ukrainian pulmonology journal. 2023;31(2):24-8. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2023-31-2-24-28
Yurko KV, Merkulova NF, Solomennyk HO, Liesna AS, Kucheriavchen VV. [Peculiarities of hemostasis disorders in patients with coronavirus infection]. Infektsiyni khvoroby. 2020;3(101):18-22. Ukrainian. doi: https://doi.org/10.11603/1681-2727.2020.3.11549
Marushchak M, Krynytska I, Homeliuk T, Vayda A, Kostiv S, Blikhar V. Charlson comorbidity index and the severity of community-acquired pneumonia caused by SARS-CoV-2: A retrospective analysis. Dental and Medical Problems. 2024;61(2):173-9. doi: https://doi.org/10.17219/dmp/166666
Avgaitis SS, Sid EV. [Activation of the immune-in flammatory response among patients with community-acquired pneumonia associated with coronavirus infection]. Actual Problems of the Modern Medicine: Bulletin of Ukrainian Medical Stomatological Academy. 2024;24(1):4-9. Ukrainian. doi: https://doi.org/10.31718/2077-1096.24.1.4
Lytvyn KY, Bilokon OO. [Factors associated with variability in IL-6 levels in patients with COVID-19]. Infektsiyni khvoroby. 2023;(2):9-14. Ukrainian. doi: https://doi.org/10.11603/1681-2727.2023.2.14097
Bilokon OO, Lytvyn KY. [Evaluation of the Level of Serum Interleukin-10 Depending on the Demographic and General Clinical and Laboratory Characteristics of the Coronavirus Disease-19 in Hospitalized Patients]. Tuberculosis, Lung Diseases, HIV Infection. 2024;(1):21-7. Ukrainian. doi: https://doi.org/10.30978/TB2024-1-21
Skakun OZ, Serediuk NM. Ferritin level predicts in-hospital mortality in hypertensive patients with COVID-19. Zaporozhye medical journal. 2023;25(1):11-5. doi: https://doi.org/10.14739/2310-1210.2023.1.266424
Agdamag ACC, Edmiston JB, Charpentier V, Chowdhury M, Fraser M, Maharaj VR, et al. Update on COVID-19 myocarditis. Medicina. 2020;56(12):678. doi: https://doi.org/10.3390/medicina56120678
Nicol M, Cacoub L, Baudet M, Nahmani Y, Cacoub P, Cohen‐Solal A, et al. Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome. ESC heart failure. 2020;7(6):4371-6. doi: https://doi.org/10.1002/ehf2.13047
Manuilov SM, Mykhailovska NS. [Structural and functional changes of the heart in patients with coronary heart disease who have had coronavirus disease COVID-19]. Modern medical technology. 2024;16(2):86-92. Ukrainian. doi: https://doi.org/10.14739/mmt.2024.2.301678
Pryshlyak OY, Hryzhak IH, Tylishchak ZR, Kobryn TZ. [COVID-19 in patients at risk of severe and complicated course]. Infektsiyni khvoroby. 2024;(4):4-13. Ukrainian. doi: https://doi.org/10.11603/1681-2727.2024.4.15004
Loboda A, Kaldiaieva M, Klymenko N, Smiian K, Melekhovets O, Vasilyeva O, et al. Features of COVID-19 in patients with diabetes mellitus. Eastern Ukrainian Medical Journal. 2024;12(3):660-9. doi: https://doi.org/10.21272/eumj.2024;12(3):660-669
Briukhanova TO, Zagayko AL, Lytkin DV. [Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes]. Pathologia. 2020;17(2):256-63. Ukrainian. doi: https://doi.org/10.14739/2310-1237.2020.2.212812
Voloshyna OB, Kovalchuk LI, Balashova IV, Buheruk VV, Zbitnieva VO. [Coronavirus disease: impact on risk and clinical course of cardiovascular diseases]. The Odesa Medical Journal. 2023;2(183):98-103. Ukrainian. doi: https://doi.org/10.32782/2226-2008-2023-2-18
Hovornyan AV, Ilashchuk TO. [Long-term sequelae of coronavirus disease: long COVID-19 and cardiovascular outcomes (a literature review)]. Zaporozhye medical journal. 2024;26(3):223-33. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2024.3.292858
Matsushita K, Marchandot B, Carmona A, Curtiaud A, El Idrissi A, Trimaille A, et al. Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced left ventricular ejection fraction. ESC Heart Fail. 2021;8(1):380-9. doi: https://doi.org/10.1002/ehf2.13083
Tomasoni D, Inciardi RM, Lombardi CM, Tedino C, Agostoni P, Ameri P, et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study. Eur J Heart Fail. 2020;22(12):2238-47. doi: https://doi.org/10.1002/ejhf.2052
Silaghi-Dumitrescu R, Patrascu I, Lehene M, Bercea I. Comorbidities of COVID-19 patients. Medicina. 2023;59(8):1393. doi: https://doi.org/10.3390/medicina59081393
Detsyk OZ, Burak OL, Koltsova NI, Mytnyk ZM, Kovalchuk RY. [The COVID-19 pandemic influence on the main indicators of oncological, in particular oncogynecological, morbidity and mortality in Ukraine]. Art of Medicine. 2022;6(1):33-8. Ukrainian. doi: https://doi.org/10.21802/artm.2022.1.21.33
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 O. S. Kulbachuk, Ye. V. Sid, O. V. Soloviov, A. V. Piskun
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
